4-n-acylfortimicin b derivatives and the chemical conversion of fortimicin b to fortimicin a
CA 1114809 A · Owner: Abbott Laboratories · Inventors: Martin, Jerry R.; Kurath, Paul; Tadanier, John S.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention provides 4-N-acylfortimicin B derivatives of the structure, wherein R is acyl aminoacyl, N-momoloweralkylaminoacyl, N,N-dilowaralkylaminoacyl hydroxy-substituted aminoacyl, or substituted aminoacyl of the formula -?-CH2NHR1, where R1 is an acyl radical derived from an amino acid or a short peptide, and the pharmaceutically acceptable salts thereof. The compounds are useful as intermediates for preparing 4-N-alkyl or substituted alkylfortimicin B derivatives. In addition to their utility as intermediates some of the compounds of this invention are also useful as antimicrobial agents. -1-
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted December 22, 1981. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended December 22, 1998.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.